or Try an Advanced Search...

    Technical Analysis for PRQR - ProQR Therapeutics B.V.

    Grade Last Price % Change Price Change
    D 2.01 0.50% 0.01
    PRQR closed up 0.5 percent on Wednesday, May 8, 2024, on 67 percent of normal volume.
    Earnings due: May 14
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical PRQR trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.50%
    Inside Day Range Contraction 0.50%
    Gapped Up Strength 0.50%
    20 DMA Resistance Bearish 1.00%
    Outside Day Range Expansion 1.00%
    Narrow Range Bar Range Contraction -0.50%
    Inside Day Range Contraction -0.50%
    20 DMA Resistance Bearish 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Older End-of-Day Signals for PRQR ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 7 minutes ago
    Down 2 % 7 minutes ago
    Rose Above 20 DMA about 2 hours ago
    20 DMA Support about 2 hours ago
    10 DMA Support about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PRQR Chart by TradingView
    Basic chart:

    Profile

    ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Genetic Disorder Therapeutic Gene Modulation Treatment Of Cystic Fibrosis

    Is PRQR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 23 ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
    Apr 22 ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
    Apr 19 ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
    Mar 14 ProQR Therapeutics Full Year 2023 Earnings: Misses Expectations
    Mar 13 ProQR reports FY results
    Mar 13 ProQR Announces Year End 2023 Operating and Financial Results
    Jan 19 ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
    Jan 18 Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Jan 15 While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12% gain, individual investors stood to gain the most
    Jan 5 ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration
    See more PRQR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.29
    52 Week Low 1.11
    Average Volume 173,245
    200-Day Moving Average 1.79
    50-Day Moving Average 2.13
    20-Day Moving Average 2.01
    10-Day Moving Average 1.98
    Average True Range 0.13
    RSI (14) 45.95
    ADX 21.85
    +DI 10.96
    -DI 20.08
    Chandelier Exit (Long, 3 ATRs) 2.06
    Chandelier Exit (Short, 3 ATRs) 2.21
    Upper Bollinger Bands 2.19
    Lower Bollinger Band 1.82
    Percent B (%b) 0.48
    BandWidth 18.45
    MACD Line -0.04
    MACD Signal Line -0.05
    MACD Histogram 0.0086
    Fundamentals Value
    Market Cap 162.32 Million
    Num Shares 81.2 Million
    EPS -0.51
    Price-to-Earnings (P/E) Ratio -3.92
    Price-to-Sales 36.79
    Price-to-Book 3.58
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.14
    Resistance 3 (R3) 2.14 2.09 2.11
    Resistance 2 (R2) 2.09 2.06 2.09 2.10
    Resistance 1 (R1) 2.05 2.04 2.03 2.05 2.10
    Pivot Point 2.00 2.00 1.99 2.00 2.00
    Support 1 (S1) 1.96 1.97 1.94 1.96 1.90
    Support 2 (S2) 1.91 1.95 1.91 1.90
    Support 3 (S3) 1.87 1.91 1.89
    Support 4 (S4) 1.87